Commerce Bank Sells 117,035 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Commerce Bank lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 15.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 626,331 shares of the financial services provider’s stock after selling 117,035 shares during the quarter. Commerce Bank’s holdings in iShares Biotechnology ETF were worth $82,807,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of IBB. Raymond James Financial Inc. bought a new position in iShares Biotechnology ETF in the fourth quarter worth approximately $55,010,000. Aprio Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $18,476,000. Generali Investments CEE investicni spolecnost a.s. bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $11,370,000. Independent Advisor Alliance purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth about $6,769,000. Finally, Wellington Shields Capital Management LLC grew its holdings in iShares Biotechnology ETF by 1,753.4% during the 4th quarter. Wellington Shields Capital Management LLC now owns 39,663 shares of the financial services provider’s stock worth $5,244,000 after acquiring an additional 37,523 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $118.29 on Friday. The firm has a 50-day simple moving average of $130.13 and a 200-day simple moving average of $136.01. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $150.57. The firm has a market cap of $5.29 billion, a P/E ratio of 24.21 and a beta of 0.84.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were issued a dividend of $0.1212 per share. The ex-dividend date was Tuesday, March 18th. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.